How effective is Zipsor for Joint Inflammation (Arthritis)? (a real world drug study)

Summary:

Overall ratings: 2/5
Long term ratings: 2/5

This is a phase IV clinical study of how effective Zipsor (diclofenac potassium) is for Joint inflammation and for what kind of people. The study is created by eHealthMe from 3 Zipsor users and is updated continuously.

What is Zipsor?

Zipsor has active ingredients of diclofenac potassium. It is often used in arthritis. eHealthMe is studying from 480 Zipsor users. Check the latest studies of Zipsor.

What is Joint inflammation?

Joint inflammation is found to be associated with 2,716 drugs and 2,332 conditions by eHealthMe. Check the latest studies of Joint inflammation.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.


On Aug, 23, 2026

3 people are studied for taking Zipsor in Joint inflammation

Overall effectiveness (number of people):

Does Zipsor work for your Joint inflammation (overall)?

Long term (1+ years) effectiveness (number of people):

Does Zipsor work for your Joint inflammation (long term)?

Zipsor effectiveness for Joint inflammation (number of people):

Overall:
  • not at all: 1
  • somewhat: 1
  • moderate: 1
  • high: 0
  • very high: 0
Long Term:
  • not at all: 0
  • somewhat: 1
  • moderate: 0
  • high: 0
  • very high: 0

Gender of people who take Zipsor for Joint inflammation *:

  • female: 66.67 %
  • male: 33.33 %

Age of people who take Zipsor for Joint inflammation *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 33.33 %
  • 40-49: 66.67 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Who find Zipsor more effective for Joint Inflammation?

* Approximation only. Some reports may have incomplete information.

Do you take Zipsor?

- You can start a phase IV clinical trial to monitor Zipsor safety and effectiveness.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Alternative drugs to, pros and cons of:

Treatments, associated drugs and conditions:

How the study uses the data?

The study is based on diclofenac potassium (the active ingredients of Zipsor) and Zipsor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: